Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 553
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06375486 | Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）. | ||
| NCT07038629 | Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC | ||
| NCT03731442 | Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients | ||
| NCT05651672 | Pemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 Alterations | ||
| NCT05821361 | HAIC Combined With Cadonilimab and Bevacizumab as First-line Therapy in Unresectable Hepatocellular Carcinoma | ||
| NCT05395429 | Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients | ||
| NCT05035147 | Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer | ||
| NCT06483386 | Pyrotinib and Subcutaneous Preparation of Trastuzumab Combined With Capecitabine Neoadjuvant Therapy for HER2+ Study of Breast Cancer | ||
| NCT06851260 | The Importance of Thymus Anatomy to the Radical Resection of Thyroid Cancer Surgery and the Protection of Parathyroid Function | ||
| NCT06863831 | A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC | ||
| NCT07008053 | BR Combined With OR in Treatment-naïve Marginal Zone Lymphoma | ||
| NCT03736837 | Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC | ||
| NCT05560308 | Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy | ||
| NCT01873014 | the Effect of Chinese Herbs to Treat Thyroid Diseases With Different Iodine Intake | ||
| NCT01073514 | Clinical Trial of Bile Etiology ,Proteomics and Metabonomics of Malignant Biliary Obstruction | ||
| NCT05997147 | A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma | ||
| NCT04936750 | A One-arm, Prospective Study Comparing the Effects of Different Body Composition on the Survival of Patients Undergoing Radical Concurrent Chemoradiotherapy for Esophageal Cancer | ||
| NCT03944980 | Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Advanced Lung Cancer | ||
| NCT06938503 | AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer | ||
| NCT06996288 | A Multicenter Randomized Controlled Clinical Trial of the Impact of Minimally Invasive Abdominal Surgery Esophageal Pressure Monitoring Guided Individualized PEEP on Postoperative Pulmonary Complications in Obese Patients | ||
| NCT01405079 | Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation | ||
| NCT02272894 | A Trial to Evaluate the Superior Mesenteric Vein (14V) Lymphadenectomy for Distal Advanced Gastric Cancer | ||
| NCT03358602 | Radiotherapy vs Neck Dissection for Clinical T1/2N0 Supraglottic Cancer | ||
| NCT06061146 | Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC | ||
| NCT07321015 | A Single-Arm Phase Ⅱ Study of Fluzoparib Maintenance in Platinum-sensitive Advanced Triple-Negative Breast Cance | ||
| NCT06383559 | Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients | ||
| NCT07533825 | Laparoscopic Staging for Stage III Gastric Cancer | ||
| NCT04828395 | Fluzoparib Combined With Camrelizumab for Maintenance Treatment of Locally Advanced Non-small Cell Lung Cancer | ||
| NCT07441486 | A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast Cancer | ||
| NCT07063225 | Romiplostim N01 for Chemotherapy-induced Thrombocytopenia | ||
| NCT04973306 | Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC | ||
| NCT05720533 | Disitamab Vedotin Combined With Sintilimab as First-line Treatment of Elderly Patients With Gastric Cancer | ||
| NCT07518706 | Neoadjuvant Tislelizumab-Lenvatinib vs Surgery Alone in Stage Ia HCC With Narrow Margin | ||
| NCT05507606 | Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations | ||
| NCT05025033 | Chemotherapy Combined With Apatinib and PD-1 Antibody | ||
| NCT02443064 | Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin | ||
| NCT04903652 | Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer | ||
| NCT07475234 | Rimegepant Combined With AG Chemotherapy As First-Line Treatment For Metastatic Pancreatic Ductal Adenocarcinoma | ||
| NCT06656559 | Endoscopic Retrograde Cholangiopancreatography With Radiofrequency Ablation (ERCP-RFA) Combined With Envafolimab and Surufatinib Sequential Therapy for Unresectable Biliary Tract Carcinoma | ||
| NCT03664843 | Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients | ||
| NCT07167459 | Personalized SBRT in Early-Stage Peripheral NSCLC | ||
| NCT06241079 | Multi-institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma | ||
| NCT04843215 | A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer | ||
| NCT03367884 | Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer | ||
| NCT01407822 | Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer | ||
| NCT04836728 | Phase II Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung Cancer | ||
| NCT05507593 | Study of DLL3-CAR-NK Cells in the Treatment of Extensive Stage Small Cell Lung Cancer | ||
| NCT04126811 | Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma | ||
| NCT06301100 | Single-center, Prospective Study on the Identification and Delineation of Brain and Lung Tumors and At-Risk Organs, and Functional Testing of Surrounding Tissues Based on Dual-Energy CT | ||
| NCT06102785 | Fruquintinib Combined With TAS102 for Advanced Gastric Cancer |
